Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Eosinophilic granulomatosis with polyangiitis Indication Strategy Report 2026: IL-5, Trials and Deals
23 July 2026
2026 Eosinophilic granulomatosis with polyangiitis strategy: epidemiology, IL-5 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Mast cell activation syndrome Indication Strategy Report 2026: c-Kit, Trials and Deals
23 July 2026
2026 Mast cell activation syndrome strategy: epidemiology, c-Kit biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Indolent systemic mastocytosis Indication Strategy Report 2026: c-Kit, Trials and Deals
23 July 2026
2026 Indolent systemic mastocytosis strategy: epidemiology, c-Kit biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Systemic mastocytosis Indication Strategy Report 2026: c-Kit, Trials and Deals
23 July 2026
2026 Systemic mastocytosis strategy: epidemiology, c-Kit biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Mastocytosis Indication Strategy Report 2026: c-Kit, Trials and Deals
23 July 2026
2026 Mastocytosis strategy: epidemiology, c-Kit biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Achalasia Indication Strategy Report 2026: nNOS, Trials and Deals
23 July 2026
2026 Achalasia strategy: epidemiology, nNOS biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with PatSnap…
Latest Hotspot
8 min read
Lymphocytic esophagitis Indication Strategy Report 2026: IL-13, Trials and Deals
23 July 2026
2026 Lymphocytic esophagitis strategy: epidemiology, IL-13 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Darier disease Indication Strategy Report 2026: ATP2A2, Trials and Deals
23 July 2026
2026 Darier disease strategy: epidemiology, ATP2A2 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Hailey-Hailey disease Indication Strategy Report 2026: ATP2C1, Trials and Deals
23 July 2026
2026 Hailey-Hailey disease strategy: epidemiology, ATP2C1 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Netherton syndrome Indication Strategy Report 2026: KLK5, Trials and Deals
23 July 2026
2026 Netherton syndrome strategy: epidemiology, KLK5 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Lamellar ichthyosis Indication Strategy Report 2026: TGM1, Trials and Deals
23 July 2026
2026 Lamellar ichthyosis strategy: epidemiology, TGM1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
X-linked ichthyosis Indication Strategy Report 2026: STS, Trials and Deals
23 July 2026
2026 X-linked ichthyosis strategy: epidemiology, STS biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…